News

Drug Delivery Business2h
Ypsomed to sell diabetes business, insulin delivery tech to TecMed for $517.7M
Ypsomed announced today that it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million ...
Drug Delivery Business2h
Biolinq closes $100M Series C funding round for biosensor platform
Biolinq has completed its pivotal trial and submitted its wearable biosensor to the FDA for regulatory review.
Drug Delivery Business19h
Abbott launches universal FreeStyle Libre CGM app in U.S.
Abbott recently launched a smartphone app that works with both its FreeStyle Libre 2 and FreeStyle Libre 3 CGM systems.